Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study

Introduction: Molecular residual disease detected by circulating tumor DNA (ctDNA) has been reported to be predictive of patients’ outcomes in various types of cancers after curative intent treatment. Nevertheless, additional detailed information regarding the association of longitudinal ctDNA detec...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Shuta Ohara, MD, PhD, Kenichi Suda, MD, PhD, Sumedha Sudhaman, PhD, Akira Hamada, MD, PhD, Masato Chiba, MD, PhD, Masaki Shimoji, MD, PhD, Toshiki Takemoto, MD, PhD, Ekaterina Kalashnikova, PhD, Samantha K. Cheung, PhD, Michael Krainock, MD, PhD, Jordan Feeney, BS, Himanshu Sethi, MPH, Minetta C. Liu, MD, Junichi Soh, MD, PhD, Yasuhiro Tsutani, MD, PhD, Tetsuya Mitsudomi, MD, PhD
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-03-01
Serija:	JTO Clinical and Research Reports
Teme:	Circulating tumor DNA (ctDNA) Tumor informed approach Non-small cell lung cancer (NSCLC) Prognostic factor Recurrence-free survival (RFS) Disease monitoring
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2666364324001322
Oznake:	Označite Brez oznak, prvi označite!